Life Technologies | Attività Correnti



Current Assets Cambiamento Data
Ardelyx USD 356.45M 72.35M 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Cipla INR 209.45B 15.04B 2024-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 106M 8.83M 2024-12
CSL USD 10.77B 622M 2024-06
Galapagos EUR 3.47B 132.9M 2025-03
GlaxoSmithKline GBP 17B 301M 2024-12
Grifols EUR 5.73B 404.28M 2024-12
Life Technologies USD 81.95M 5.64M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12



Life Technologies Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.